Sector | Chemicals | Compare with Sector peers |
Industry | Chemicals | Compare with Industry peers |
Website | http://www.rossari.com | |
Market Cap | 3,982.68 Cr. | |
Enterprise Value(EV) | 4,059.36 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 22.72 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 31.73 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 45.51 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 183.44 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.93 | Calculated using Price: 720.90 |
Dividend Yield | 0.07 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.52 Cr. | 55,245,966 Shares |
FaceValue | 2 | |
About Rossari Biotech Ltd. | ||
The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. The company's business is organized in three main product categories - (i) home, personal care and performance chemicals; (ii) textile specialty chemicals; and (iii) animal health and nutrition products. |
1 Day |
|
-1.87% |
1 Week |
|
+1.76% |
1 Month |
|
+1.65% |
3 Month |
|
-6.88% |
6 Month |
|
-10.11% |
1 Year |
|
+4.84% |
2 Year |
|
-24.84% |
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 8.18 | 6.99 | 27.27 | 36.33 | 41.88 | 31.83 | 23.11 | 16.17 | 12.52 | |
Return on Capital Employed (%) | 10.7 | 10.3 | 26.4 | 40.37 | 54.4 | 37.93 | 28.81 | 24.37 | 18.48 | |
Return on Assets (%) | 3.11 | 3.04 | 13.49 | 20 | 20.38 | 16.17 | 13.69 | 9.48 | 7.18 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 47 | 50 | 65 | 94 | 124 | 287 | 409 | 805 | 915 | 978 | |
Non Curr. Liab. | 9 | 7 | 2 | 4 | 37 | 69 | 59 | 251 | 183 | 83 | |
Curr. Liab. | 58 | 52 | 57 | 68 | 122 | 169 | 177 | 360 | 474 | 469 | |
Minority Int. | |||||||||||
Equity & Liab. | 114 | 109 | 124 | 166 | 283 | 525 | 645 | 1,417 | 1,572 | 1,530 | |
Non Curr. Assets | 46 | 46 | 47 | 60 | 123 | 178 | 263 | 742 | 723 | 687 | |
Curr. Assets | 69 | 63 | 77 | 106 | 160 | 346 | 381 | 675 | 848 | 843 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 114 | 109 | 124 | 166 | 283 | 525 | 645 | 1,417 | 1,572 | 1,530 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 171 | 179 | 233 | 292 | 516 | 600 | 709 | 1,483 | 1,656 | 1,764 | |
Other Income | 0 | 0 | 1 | 1 | 1 | 4 | 9 | 19 | 14 | 10 | |
Total Income | 171 | 179 | 234 | 293 | 517 | 604 | 719 | 1,502 | 1,670 | 1,774 | |
Total Expenditure | -156 | -166 | -209 | -247 | -439 | -495 | -586 | -1,307 | -1,441 | -1,525 | |
PBIDT | 15 | 13 | 25 | 46 | 78 | 108 | 132 | 195 | 229 | 249 | |
Interest | -5 | -4 | -2 | -1 | -3 | -4 | -3 | -13 | -22 | -20 | |
Depreciation | -5 | -5 | -4 | -5 | -12 | -17 | -23 | -48 | -63 | -60 | |
Taxation | -1 | -1 | -3 | -11 | -18 | -23 | -27 | -39 | -37 | -44 | |
Exceptional Items | |||||||||||
PAT | 4 | 3 | 16 | 29 | 46 | 65 | 80 | 98 | 107 | 125 | |
Minority Interest | 0 | 0 | |||||||||
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 4 | 3 | 16 | 29 | 46 | 65 | 80 | 98 | 107 | 126 | |
Adjusted EPS | 1 | 1 | 3 | 6 | 9 | 13 | 15 | 18 | 19 | 23 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 24 | 71 | 57 | 48 | 29 | 152 | |
Cash Fr. Inv. | -20 | -36 | -190 | -37 | -299 | -181 | |
Cash Fr. Finan. | -5 | -29 | 157 | -25 | 292 | 61 | |
Net Change | -2 | 6 | 23 | -14 | 22 | 32 | |
Cash & Cash Eqvt | 1 | 6 | 29 | 15 | 37 | 70 |
Fri, 12 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Parul Gupta Designation: Company Secretary and Compliance Officer EmailId: investors@rossari.com Name of the Chief Financial Officer: Ketan Sablok Designation: Group Chief Financial Officer EmailId: ketan.sablok@rossari.com Date: 12/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
|||||||||||||||||||||
Sat, 06 Apr 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On April 06 2024 The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Dubai United Arab Emirates and Appointment of Mr. Sunil V as Chief Human Resource Officer and other matters. |
|||||||||||||||||||||
Fri, 05 Apr 2024
Compliance Certificate Pursuant To Regulation 40(10) Compliance Certificate issued by Mr. Sanjay Dholakia of Sanjay Dholakia & Associates Practicing Company Secretaries for the period April 01 2023 to March 31 2024. |
Fri, 19 Apr 2024 |
Opening at Low |
Closing Below Previous Low |
Close Within 52 Week Low Zone |
CCI Bearish |
William %R Bearish |